肾系内伤基础上外感病之一感冒的证治初探
摘要
肾系内伤基础上的外感是临床常见的疾病之一,属本虚之中又兼邪实范畴,临床常见,多发,较之单纯的外感,处理更为棘手。肾系内伤是指原有慢性肾脏疾病,如：原发性肾小球肾炎,肾病综合征,糖尿病肾病,高血压肾病,慢性肾功能不全等。肾系内伤基础上的外感是一种发生在这样的慢性肾系疾病基础之上,并有外感临床表现的整体疾病状态,而不是慢性肾脏疾病和外感的简单相加。因肾系疾病有其本身的临床特点,故而发生在其基础上的外感病也必然有其特殊性。本研究建立在导师外感病的内伤基础理论之上,探讨肾系内伤基础上外感的证治特点,并且总结导师运用外感病的内伤基础理论治疗肾系内伤基础上外感病的经验。
本研究分为理论探讨、临床研究和结论三部分。
一理论探讨
肾系内伤基础上的外感是一种复杂的临床状态,既有外感的情况存在,又有肾系疾病内伤的情况存在,病因病机复杂,临床表现多样且病情多变。肾系疾病患者因其疾病特点影响,而表现出对外感病的易患性,其临床经过不同于其他外感病的一般规律而有其自身的特殊性。
肾系疾病在发病初期,多仅表现为肾气亏虚,病久则阴阳失调,五脏俱损。脏腑功能失调,津液代谢障碍,气血运行受阻,三焦疏泄不利,易致痰浊瘀血内生,全身脉络瘀阻,气血失于流通,相关脏腑器官失去濡养而发生诸多变证。病变后期,阴阳俱虚,脾肾衰败,浊毒内停,危及生命。肾系内伤者外感发病后,整体病机发生变化,既不同于单纯的肾系内伤疾病,也不同于普通的感冒,而是在原有阴阳气血失调的基础上出现肺失宣肃,痰浊瘀血互阻于肺,在标有“肺卫失宣”,在本有“阴阳失调”。病理因素复杂多变,痰浊瘀血胶着难解,脏腑、三焦、经络、气血均不循常规、阻滞难通。
肾系内伤患者外感时常表现出发病的不典型性和症状的不典型,病程中可见痰浊瘀血、三焦阻滞、疏泄不利等表现,瘀象贯穿始终,还有患者肝气受到影响而郁滞,使症状纷纭、证候更为复杂。大多患者不能用单一的证候类型概括其疾病特征。
肾系内伤基础上外感病的辨证,需将脏腑辨证与三焦辨证相结合分析。从脏腑辨证来看,应分属肺、脾、肾三脏功能失常,若按照三焦辨证,则涉及上、中、下三焦,肺属上焦,脾属中焦,肾归下焦,其在脏腑辨证理论体系中的传变路径则可转换成上中下三焦之间的传变。
肾系内伤疾病患者兼感外邪,证候复杂,症状累及多方面,常表里同病、虚实夹杂,病情较复杂,病势缠绵,常累及机体多个脏腑,在病机的把握上难度较大。在治疗上,既要补益肺脾肾三脏之虚,更要疏理三焦气机、通阳化气行水。这就要以三焦脏腑为切入点,运用和解少阳、疏利三焦的方法治疗,通过调整人体表里、内外状态的平衡,使气机条达,血脉通畅。
二临床研究
第一部分：有肾系内伤基础外感和无肾系内伤基础外感的前瞻性对照性研究
1.病例来源
临床收集2009年1月至2010年1月在姜良铎教授门诊、东直门医院肾病科病房及门诊就诊,符合慢性肾脏病诊断同时有急性上呼吸道感染的患者102例为观察组,同期收集在姜良铎教授门诊、东直门医院急诊、中日医院急诊就诊,符合急性上呼吸道感染,并能够按照性别、年龄与观察组进行1：1配比的患者102例为对照组Ⅰ。102例观察组患者中,来源于门诊者83人,来源于病房者19人。102例对照组Ⅰ患者中,来源于门诊者58人,来源于急诊者64人。各组男性35人,女性67人,男：女=1：1.9。
2.两组患者外感季节的分布
两组患者的外感病发病季节,以冬季最多,春季、秋季次之,夏季最少。说明寒邪和燥邪是肾系内伤基础上外感致病的主要因素。
3.两组患者外感时体温的变化
观察组患者体温无明显升高者64人,(占本组患者的62.75%),仅有27人(占本组患者的26.47%)体温在38℃以上；对照组Ⅰ患者体温无明显升高者34人,(占本组患者的33.33%),体温在38℃以上者有45人(占本组患者的44.12%)。
4.两组患者外感病程的分布
观察组患者外感病程以8-14天最多(50.98%),15-30天其次(34.31%),而≤7天(11.76%)和>30天(2.94%)相对较少。对照组Ⅰ患者外感病程以≤7天最多(57.84%),8-14天其次(40.20%),15-30天最少(1.96%),>30天者为O。
5.两组患者外感前后肾功能的变化
观察组患者外感发病72小时内和外感痊愈后肾功能均较外感发病前有明显降低,对照组Ⅰ患者外感发病前后肾功能无明显变化。
6.两组患者外感前后伴随症状的变化
观察组患者外感发病前临床症状多样,外感发病72小时内伴随症状进一步加重,外感病痊愈后伴随症状仍存在。对照组Ⅰ患者外感发病后偶有伴随症状,外感病痊愈后伴随症状大多能够消失。
7.两组患者外感发病后舌象的变化
观察组患者外感发病72小时内和外感病痊愈后内舌质均以暗(包括暗、暗红、暗淡、紫暗)为主,舌苔均以腻(包括白腻、黄腻)为主；对照组Ⅰ患者外感发病72小时内舌质以红为主,外感病痊愈后舌质以淡红为主,舌苔均以薄白、薄黄为主,
8.两组患者外感发病前后脉象的变化
观察组患者外感病前后单一脉象均以沉、细、弦为主；对照组Ⅰ患者单一脉象外感发病72小时内以浮、数、弦为主,外感病痊愈后以弦、和缓、细为主。
9.两组患者外感证候的分布
观察组患者外感病在卫表证上常伴有阳虚、阴虚、阴阳两虚、痰湿、瘀血或肝郁证候；对照组Ⅰ患者外感病多只有卫表证。
第二部分：运用外感病的内伤基础理论治疗肾系内伤基础上外感病的疗效对比
1.病例来源
在观察组中,抽取39例经姜良铎教授中药治疗的患者为治疗组,同时抽取能够按照性别、年龄、外感发病前肾功能与治疗组进行1：1配比的未经姜良铎教授中药治疗的39例患者为对照组Ⅱ。治疗组患者均来源于姜良铎教授门诊,对照组Ⅱ患者来源于东直门医院肾病科病房者7人,来源于其它门诊者22人。各组男性13人,女性26人,男：女=1：2。
2.治疗方法
采用配比及自身前后对照研究。治疗组患者经导师运用外感病的内伤基础理论,结合患者自身状况,给予辨证中药汤剂治疗,治疗方案以中药汤剂为主；对照组Ⅱ患者未经导师中药汤剂治疗,其治疗方案以抗菌素及中成药治疗为主。
3.两组患者外感病病程比较
治疗组患者外感病病程8-14天者最多(66.67%),≤7天者其次(20.51%),>15天者最少(12.82%)；对照组Ⅱ患者外感病病程8-14天者最多(53.85%),≥15天者其次(38.46%),≤7天者最少(7.69%)。
4.两组患者外感病前后肾功能情况比较
治疗组和对照组Ⅱ两组患者外感前和外感发病72小时内肾功能均无差异,外感病痊愈后肾功能有显著差异,对照组Ⅱ患者的肾功能要明显低于治疗组。
5.两组患者外感病前后伴随症状的变化比较
外感发病72小时内,两组患者伴随症状积分相似,无显著差异；外感病痊愈后两组患者有多组伴随症状积分差异显著。经治疗后,治疗组患者多组伴随症状均有减轻,对照组Ⅱ患者伴随症状改善情况较差。
6.两组患者用药比较
治疗组患者经导师中药汤剂治疗,所用中药方剂以柴胡剂为主,根据用药频次统计,排在前30味的中药是：柴胡,黄芩,赤白芍,黄芪,桂枝,生甘草,知母,荆芥,姜半夏,防风,牛蒡子,党参,丹皮,白术,猪苓,熟大黄,女贞子,连翘,三七,瓜蒌,金银花,苏叶,仙鹤草,炒杏仁,菊花,当归,桑叶,丹参,地黄,枳壳实。
对照组Ⅱ患者未经导师中药汤剂治疗,多使用抗菌素和中成药治疗,有一部分患者未服用任何药物。
三结论
1.肾系内伤基础上外感病机复杂多变,多表现为本虚标实之证,本虚为阳虚、阴虚、阴阳两虚,标实为痰湿、瘀血、肝郁。
2.肾系内伤基础会使外感病病程延长,病势缠绵难愈,外感病也会加重原有肾系内伤疾病。
3.三焦郁滞是肾系内伤基础上外感病的一个重要病机,治疗上应从三焦脏腑入手,疏利三焦,多用柴胡剂治疗,针对原有肾系内伤疾病,要注重补气活血,通阳化气利水,兼顾脾胃之能；针对外感之邪,选药宜无寒热偏重,药味轻灵之品。
4.外感病的内伤基础理论是一种有效的临床中医理论,源于临床实践,既继承了辨证论治的精髓,又吸收了现代科学的新成果,实践证明它能有效地指导临床,因而值得推广应用。
"External disease based on internal damage of the Kidney system" is one of the common clinical diseases and belongs to deficiency pattern complicated with excessive-pathogenic patthern category, which the treatment is more difficult than simple disease caused by exogenous pathogenic factors. Kidney internal injury includes the original kidney diseases, such as:primary glomerular nephritis, nephritic syndrome, diabetic nephropathy, hypertensive nephropathy, chronic renal insufficiency, etc. "External disease based on internal damage of the Kidney system" is a holistic pathologic status, which based on these set of chronic Kidney diseases with the exogenous symptoms, rather than simple addition of chronic kidney disease and exogenous. Kidney disease has its own clinical characteristics, so External diseases based on it have also its particularity. This research is establish on the theories of external diseases based on the internal injuries, and to investigate the pattern and treatment characteristics of on diseases of Kidney system, and also it concluded the experience of adviser's clinical treatment method, on external disease based on internal damage of the Kidney system, by use of external diseases of the internal injuries theory.
This paper is divided into three parts:theoretical discussion, clinical research and the conclusion.
1 Theoretical discussion
External disease based on internal damage of the Kidney system is a complicated clinical status which includes both the exogenous and the internal damage of the Kidney system with multiple etiological factors, pathogenesis and clinical manifestations. Because of the characteristics of Kidney disease, Patients are more vulnerable to exogenous pathogens attack, its clinical course different from other external diseases of the general principle and has its own special characteristics.
In the early stage of kidney disease, mostly expressing on kidney deficiency, yin and yang imbalance in chronic disease, and all five organs damage. Dysfunctional in organs, body fluid metabolism disorders, blockage in qi and blood flow, flow or triple energizer interrupted, it prone to cause phlegm and stasis endogenous, systemic blood vessels stasis, qi and blood flow damaged in circulation, relevant zang-fu viscera loss its nutrient and complicated syndrome happened. In late stage, yin and yang deficiency, spleen and kidney decay, toxin stop inside, finally become life-threatening. Exogenous Kidney disease in the injured, the overall pathogenesis change is different from the simple internal injuries of Kidney disease, and it is also different from the common cold. It is original basis of yin and yang, qi and blood disorders, then lets to Lung disorder, phlegm and blood stasis block in the lung, which caused by "Lung and wei-qi impairment" and the root caused is "yin and yang imbalance". Pathological factors is complex and change easily, phlegm and blood stasis stalemate incomprehensible, zang-fu viscera, triple energizer, meridians, qi and blood are not in normal principle, blockage and difficult to hard to dredge.
Patients with Kidney disease often show non-typical and atypical symptoms, In the course of disease, phlegm stasis, triple burner block and Negative catharsis can be seen, stasis is always existence. Liver stagnation can be effected, the symptoms becoming diverse and complex. It can not use a single type of general syndrome to sum up.
Department of External disease based on internal damage of the Kidney system combine the Visceral Syndrome with Triple Burner Syndrome. In the Visceral Syndrome, it belongs to the lung, spleen and kidney, if in accordance with the triple burner syndrome, involves the upper, middle and lower triple burner. The transmission path in the Visceral Syndrome becomes the upper, middle and lower triple burner.
Patients with Kidney disease and exogenous pathogens, symptoms are complex, multiple body organs will be involved and pathogenesis is difficult to hold. In treatment, it is necessary to benefit lung, spleen and kidney and reorganizing the triple burner. This requires to starting from triple burner organs, using reconciliation Shao Yang and Shu Li triple burner method, by adjusting the state of balance in human body, to make qi and blood smooth.
2 Clinical research
PartⅠ:Forward-looking and Control of study between external disease based on internal damage of the Kidney system and external disease without internal damage of the Kidney system.
1. Case Source
102 observation group Patients are collected from January 2009 to January 2010 in Liang-duo Jiang Professor, Dongzhimen Hospital, Consistent with diagnosis of chronic kidney disease and Acute upper respiratory tract infection.102 control group I patients were collected in Liang-Duo Jiang Professor, Dongzhimen hospital emergency station, the Sino-Japanese hospital emergency station, consistent with acute upper respiratory tract infection, and can 1:1 ratio with observation group Patients according to gender and age.102 cases of observation group patients,83 were from out-patient,19 were from wards.102 cases of control groupⅠpatients,58 were from out-patient, and 64 were from emergency room. In each group, there were 35 male and 67 females, male:female= 1:1.9.
2. Exogenous disease seasonal distribution of the two groups
About two groups of exogenous disease season, the first was winter, spring and autumn followed, and the last was summer. Cold and dry evil are the main pathogenic factor.
3. Temperature changes of two groups
64 patients in the observation group had no significant increase in body temperature (accounting for 62.75% of patients in this group), only 27 people's (accounting for 26.47% of patients in this group) temperature above 38℃; In the control group I,34 patients had significantly increase in body temperatures (accounting for 33.33%of patients in this group),45 people's body temperature above 38℃(accounting for 44.12% of patients in this group).
4. Exogenous disease course of two groups
Patients in the observation group with exogenous course of 8-14 days were most (50.98%), followed by 15-30 days (34.31%), and≤7 days (11.76%) and> 30 days (2.94%) were relatively least. Patients in the control group I with≤7天course were most (57.84%), followed by 8-14 days (40.20%),15-30 days at least (1.96%),> 30 days were 0.
5. Changes in renal function between two groups before and after the exogenous disease
After the exogenous disease, renal function in the observation group becomes lower. But in control group I was no significant changes.
6. Changes of symptoms between the two groups before and after the exogenous disease
Before the exogenous disease, symptoms in the observation group patients were varied, these symptoms were further increase among the exogenous disease, after the exogenous disease, symptoms were still exists. In control group I, some symptoms can appear among the exogenous disease, but after the exogenous disease can disappear.
7. Changes in tongue of the two groups
Patients tongue in the observation group are dark-based (including the dark, dark, dim, dark purple), tongue are tired of (including greasy, yellow and greasy) dominated; Patients tongue in control group I were red-based within 72 hours, after external disease was treatment, mainly with pink, white tongue coating are thin, thin yellow-based,
8. Changes in pulse of the two groups
The single pulse in the observation group are heavy, thin, string-based; in the control group I are floating, number and string-based within 72 hours, after external disease was treatment were string, moderate and mainly fine.
9. Stasis in both groups
In addition to the evidence of external diseases, deficiency of yang, deficiency of yin, deficiency of yang and yin, phlegm, blood stasis and stagnation of liver are existence in the observation group; But in the control group I, only the evidence of external diseases can be seen.
PartⅡ:Contrasting between external disease based on internal damage of the Kidney system and external disease without internal damage of the Kidney system by using theory of external diseases based on internal damage.
1. Case Source
In the observation group,39 treatment group cases collected from liang-Duo Jiang Professor's out by treating with traditional Chinese medicine,39 control groupⅡcases were without Liang-duo Jiang Professor treatment, but can 1:1 ratio with treatment group Patients according to gender, age and renal function. Treatment group were all from Liang-duo Jiang Professor Patient, in the control groupⅡ7 patients were from Dongzhimen Hospital Nephrology wards,22 were from other clinics, In each group, there were 13 males and 26 females, male:female=1:2.
2. Treatment
Using study of self-control and compared with oneself before and after. Treatment group treatment by using theory of external diseases based on internal damage, combined with patient's own situation, different decoction was given different patient; control groupⅡwithout a mentor Decoction of patients, their treatment protocols were antibiotics and proprietary therapy.
3. Exogenous disease course of two groups
Exogenous disease course of patients with 8-14 days was maximum (66.67%),≤7 days followed (20.51%),≥15 days was the least (12.82%); control groupⅡexogenous disease course in patients with 8-14 days was maximum of (53.85%),≥15 days followed (38.46%),≤7 days was the least (7.69%).
4. Changes in renal function between two groups before and after the exogenous disease
Renal function had no difference between treatment group and control groupⅡbefore and within 72 hours of external disease, it changed after external disease. And renal function becomes lower in the control groupⅡ.
5. Changes of symptoms between the two groups before and after the exogenous disease
Within 72 hours, two groups of patients with similar symptoms scores, no significant difference; after external disease, patients were more significant differences associated with symptom score. After treatment, the treatment groups of patients with symptoms were alleviated, the control groupⅡpatients with poor symptom improvement.
6. Comparison of two groups of patients with medication
Treatment group are treatment by using theory of external diseases based on internal damage, Chinese herbal formula used by the main agent, according to agent frequency statistics, the top 30 flavor of traditional Chinese medicine are:Bupleurum, Scutellaria root, red peony root, astragalus, Guizhi, raw licorice, Zhimu, CARVACROL, Jiang Ban Xia, wind, Arctium, Codonopsis, paeonol, Atractylodes, Polyporus, Cooked rhubarb, Ligustrum lucidum, forsythia, san qi, Trichosanthes, honeysuckle, mulberry leaves, crane grass, fried almonds, Chrysanthemum, Angelica, mulberry leaf, red sage root, Rehmannia, Fructus real.
Control groupⅡwithout a mentor Decoction of patients, greater use of antibiotics and traditional Chinese medicine, some patients were not taking any medications.
3 Conclusion
1. Pathogenesis of External disease based on internal damage of the Kidney system is complex, deficiency of yang, deficiency of yin, deficiency of yin and yang are the virtual, phlegm, blood stasis, stagnation are also existence.
2. Internal damage of the Kidney system will extend external diseases, disease potential will hard to be cured, external diseases will increase the existing Department of internal injury of renal disease.
3. Sanjiao stagnation is an important pathogenesis in external disease based on internal damage of the Kidney system, treatment should start organs triple burner, Bupleurum are used usually, About internal injury of kidney disease, we should pay attention to benefit qi and make xue live, Li Yang of gas water, spleen and stomach should be taken into account; Against the evil of exogenous drug selection and emphasis should not cold and heat.
4. The theory of external diseases based on internal damage is effective clinical medicine; it comes from clinical practice, not only inherits the essence of the diagnosis and therapy, but also absorbed the new achievements of modern science. It has been proved effectively and can guide Clinical, therefore should be widely applied.
本研究分为理论探讨、临床研究和结论三部分。
一理论探讨
肾系内伤基础上的外感是一种复杂的临床状态,既有外感的情况存在,又有肾系疾病内伤的情况存在,病因病机复杂,临床表现多样且病情多变。肾系疾病患者因其疾病特点影响,而表现出对外感病的易患性,其临床经过不同于其他外感病的一般规律而有其自身的特殊性。
肾系疾病在发病初期,多仅表现为肾气亏虚,病久则阴阳失调,五脏俱损。脏腑功能失调,津液代谢障碍,气血运行受阻,三焦疏泄不利,易致痰浊瘀血内生,全身脉络瘀阻,气血失于流通,相关脏腑器官失去濡养而发生诸多变证。病变后期,阴阳俱虚,脾肾衰败,浊毒内停,危及生命。肾系内伤者外感发病后,整体病机发生变化,既不同于单纯的肾系内伤疾病,也不同于普通的感冒,而是在原有阴阳气血失调的基础上出现肺失宣肃,痰浊瘀血互阻于肺,在标有“肺卫失宣”,在本有“阴阳失调”。病理因素复杂多变,痰浊瘀血胶着难解,脏腑、三焦、经络、气血均不循常规、阻滞难通。
肾系内伤患者外感时常表现出发病的不典型性和症状的不典型,病程中可见痰浊瘀血、三焦阻滞、疏泄不利等表现,瘀象贯穿始终,还有患者肝气受到影响而郁滞,使症状纷纭、证候更为复杂。大多患者不能用单一的证候类型概括其疾病特征。
肾系内伤基础上外感病的辨证,需将脏腑辨证与三焦辨证相结合分析。从脏腑辨证来看,应分属肺、脾、肾三脏功能失常,若按照三焦辨证,则涉及上、中、下三焦,肺属上焦,脾属中焦,肾归下焦,其在脏腑辨证理论体系中的传变路径则可转换成上中下三焦之间的传变。
肾系内伤疾病患者兼感外邪,证候复杂,症状累及多方面,常表里同病、虚实夹杂,病情较复杂,病势缠绵,常累及机体多个脏腑,在病机的把握上难度较大。在治疗上,既要补益肺脾肾三脏之虚,更要疏理三焦气机、通阳化气行水。这就要以三焦脏腑为切入点,运用和解少阳、疏利三焦的方法治疗,通过调整人体表里、内外状态的平衡,使气机条达,血脉通畅。
二临床研究
第一部分：有肾系内伤基础外感和无肾系内伤基础外感的前瞻性对照性研究
1.病例来源
临床收集2009年1月至2010年1月在姜良铎教授门诊、东直门医院肾病科病房及门诊就诊,符合慢性肾脏病诊断同时有急性上呼吸道感染的患者102例为观察组,同期收集在姜良铎教授门诊、东直门医院急诊、中日医院急诊就诊,符合急性上呼吸道感染,并能够按照性别、年龄与观察组进行1：1配比的患者102例为对照组Ⅰ。102例观察组患者中,来源于门诊者83人,来源于病房者19人。102例对照组Ⅰ患者中,来源于门诊者58人,来源于急诊者64人。各组男性35人,女性67人,男：女=1：1.9。
2.两组患者外感季节的分布
两组患者的外感病发病季节,以冬季最多,春季、秋季次之,夏季最少。说明寒邪和燥邪是肾系内伤基础上外感致病的主要因素。
3.两组患者外感时体温的变化
观察组患者体温无明显升高者64人,(占本组患者的62.75%),仅有27人(占本组患者的26.47%)体温在38℃以上；对照组Ⅰ患者体温无明显升高者34人,(占本组患者的33.33%),体温在38℃以上者有45人(占本组患者的44.12%)。
4.两组患者外感病程的分布
观察组患者外感病程以8-14天最多(50.98%),15-30天其次(34.31%),而≤7天(11.76%)和>30天(2.94%)相对较少。对照组Ⅰ患者外感病程以≤7天最多(57.84%),8-14天其次(40.20%),15-30天最少(1.96%),>30天者为O。
5.两组患者外感前后肾功能的变化
观察组患者外感发病72小时内和外感痊愈后肾功能均较外感发病前有明显降低,对照组Ⅰ患者外感发病前后肾功能无明显变化。
6.两组患者外感前后伴随症状的变化
观察组患者外感发病前临床症状多样,外感发病72小时内伴随症状进一步加重,外感病痊愈后伴随症状仍存在。对照组Ⅰ患者外感发病后偶有伴随症状,外感病痊愈后伴随症状大多能够消失。
7.两组患者外感发病后舌象的变化
观察组患者外感发病72小时内和外感病痊愈后内舌质均以暗(包括暗、暗红、暗淡、紫暗)为主,舌苔均以腻(包括白腻、黄腻)为主；对照组Ⅰ患者外感发病72小时内舌质以红为主,外感病痊愈后舌质以淡红为主,舌苔均以薄白、薄黄为主,
8.两组患者外感发病前后脉象的变化
观察组患者外感病前后单一脉象均以沉、细、弦为主；对照组Ⅰ患者单一脉象外感发病72小时内以浮、数、弦为主,外感病痊愈后以弦、和缓、细为主。
9.两组患者外感证候的分布
观察组患者外感病在卫表证上常伴有阳虚、阴虚、阴阳两虚、痰湿、瘀血或肝郁证候；对照组Ⅰ患者外感病多只有卫表证。
第二部分：运用外感病的内伤基础理论治疗肾系内伤基础上外感病的疗效对比
1.病例来源
在观察组中,抽取39例经姜良铎教授中药治疗的患者为治疗组,同时抽取能够按照性别、年龄、外感发病前肾功能与治疗组进行1：1配比的未经姜良铎教授中药治疗的39例患者为对照组Ⅱ。治疗组患者均来源于姜良铎教授门诊,对照组Ⅱ患者来源于东直门医院肾病科病房者7人,来源于其它门诊者22人。各组男性13人,女性26人,男：女=1：2。
2.治疗方法
采用配比及自身前后对照研究。治疗组患者经导师运用外感病的内伤基础理论,结合患者自身状况,给予辨证中药汤剂治疗,治疗方案以中药汤剂为主；对照组Ⅱ患者未经导师中药汤剂治疗,其治疗方案以抗菌素及中成药治疗为主。
3.两组患者外感病病程比较
治疗组患者外感病病程8-14天者最多(66.67%),≤7天者其次(20.51%),>15天者最少(12.82%)；对照组Ⅱ患者外感病病程8-14天者最多(53.85%),≥15天者其次(38.46%),≤7天者最少(7.69%)。
4.两组患者外感病前后肾功能情况比较
治疗组和对照组Ⅱ两组患者外感前和外感发病72小时内肾功能均无差异,外感病痊愈后肾功能有显著差异,对照组Ⅱ患者的肾功能要明显低于治疗组。
5.两组患者外感病前后伴随症状的变化比较
外感发病72小时内,两组患者伴随症状积分相似,无显著差异；外感病痊愈后两组患者有多组伴随症状积分差异显著。经治疗后,治疗组患者多组伴随症状均有减轻,对照组Ⅱ患者伴随症状改善情况较差。
6.两组患者用药比较
治疗组患者经导师中药汤剂治疗,所用中药方剂以柴胡剂为主,根据用药频次统计,排在前30味的中药是：柴胡,黄芩,赤白芍,黄芪,桂枝,生甘草,知母,荆芥,姜半夏,防风,牛蒡子,党参,丹皮,白术,猪苓,熟大黄,女贞子,连翘,三七,瓜蒌,金银花,苏叶,仙鹤草,炒杏仁,菊花,当归,桑叶,丹参,地黄,枳壳实。
对照组Ⅱ患者未经导师中药汤剂治疗,多使用抗菌素和中成药治疗,有一部分患者未服用任何药物。
三结论
1.肾系内伤基础上外感病机复杂多变,多表现为本虚标实之证,本虚为阳虚、阴虚、阴阳两虚,标实为痰湿、瘀血、肝郁。
2.肾系内伤基础会使外感病病程延长,病势缠绵难愈,外感病也会加重原有肾系内伤疾病。
3.三焦郁滞是肾系内伤基础上外感病的一个重要病机,治疗上应从三焦脏腑入手,疏利三焦,多用柴胡剂治疗,针对原有肾系内伤疾病,要注重补气活血,通阳化气利水,兼顾脾胃之能；针对外感之邪,选药宜无寒热偏重,药味轻灵之品。
4.外感病的内伤基础理论是一种有效的临床中医理论,源于临床实践,既继承了辨证论治的精髓,又吸收了现代科学的新成果,实践证明它能有效地指导临床,因而值得推广应用。
"External disease based on internal damage of the Kidney system" is one of the common clinical diseases and belongs to deficiency pattern complicated with excessive-pathogenic patthern category, which the treatment is more difficult than simple disease caused by exogenous pathogenic factors. Kidney internal injury includes the original kidney diseases, such as:primary glomerular nephritis, nephritic syndrome, diabetic nephropathy, hypertensive nephropathy, chronic renal insufficiency, etc. "External disease based on internal damage of the Kidney system" is a holistic pathologic status, which based on these set of chronic Kidney diseases with the exogenous symptoms, rather than simple addition of chronic kidney disease and exogenous. Kidney disease has its own clinical characteristics, so External diseases based on it have also its particularity. This research is establish on the theories of external diseases based on the internal injuries, and to investigate the pattern and treatment characteristics of on diseases of Kidney system, and also it concluded the experience of adviser's clinical treatment method, on external disease based on internal damage of the Kidney system, by use of external diseases of the internal injuries theory.
This paper is divided into three parts:theoretical discussion, clinical research and the conclusion.
1 Theoretical discussion
External disease based on internal damage of the Kidney system is a complicated clinical status which includes both the exogenous and the internal damage of the Kidney system with multiple etiological factors, pathogenesis and clinical manifestations. Because of the characteristics of Kidney disease, Patients are more vulnerable to exogenous pathogens attack, its clinical course different from other external diseases of the general principle and has its own special characteristics.
In the early stage of kidney disease, mostly expressing on kidney deficiency, yin and yang imbalance in chronic disease, and all five organs damage. Dysfunctional in organs, body fluid metabolism disorders, blockage in qi and blood flow, flow or triple energizer interrupted, it prone to cause phlegm and stasis endogenous, systemic blood vessels stasis, qi and blood flow damaged in circulation, relevant zang-fu viscera loss its nutrient and complicated syndrome happened. In late stage, yin and yang deficiency, spleen and kidney decay, toxin stop inside, finally become life-threatening. Exogenous Kidney disease in the injured, the overall pathogenesis change is different from the simple internal injuries of Kidney disease, and it is also different from the common cold. It is original basis of yin and yang, qi and blood disorders, then lets to Lung disorder, phlegm and blood stasis block in the lung, which caused by "Lung and wei-qi impairment" and the root caused is "yin and yang imbalance". Pathological factors is complex and change easily, phlegm and blood stasis stalemate incomprehensible, zang-fu viscera, triple energizer, meridians, qi and blood are not in normal principle, blockage and difficult to hard to dredge.
Patients with Kidney disease often show non-typical and atypical symptoms, In the course of disease, phlegm stasis, triple burner block and Negative catharsis can be seen, stasis is always existence. Liver stagnation can be effected, the symptoms becoming diverse and complex. It can not use a single type of general syndrome to sum up.
Department of External disease based on internal damage of the Kidney system combine the Visceral Syndrome with Triple Burner Syndrome. In the Visceral Syndrome, it belongs to the lung, spleen and kidney, if in accordance with the triple burner syndrome, involves the upper, middle and lower triple burner. The transmission path in the Visceral Syndrome becomes the upper, middle and lower triple burner.
Patients with Kidney disease and exogenous pathogens, symptoms are complex, multiple body organs will be involved and pathogenesis is difficult to hold. In treatment, it is necessary to benefit lung, spleen and kidney and reorganizing the triple burner. This requires to starting from triple burner organs, using reconciliation Shao Yang and Shu Li triple burner method, by adjusting the state of balance in human body, to make qi and blood smooth.
2 Clinical research
PartⅠ:Forward-looking and Control of study between external disease based on internal damage of the Kidney system and external disease without internal damage of the Kidney system.
1. Case Source
102 observation group Patients are collected from January 2009 to January 2010 in Liang-duo Jiang Professor, Dongzhimen Hospital, Consistent with diagnosis of chronic kidney disease and Acute upper respiratory tract infection.102 control group I patients were collected in Liang-Duo Jiang Professor, Dongzhimen hospital emergency station, the Sino-Japanese hospital emergency station, consistent with acute upper respiratory tract infection, and can 1:1 ratio with observation group Patients according to gender and age.102 cases of observation group patients,83 were from out-patient,19 were from wards.102 cases of control groupⅠpatients,58 were from out-patient, and 64 were from emergency room. In each group, there were 35 male and 67 females, male:female= 1:1.9.
2. Exogenous disease seasonal distribution of the two groups
About two groups of exogenous disease season, the first was winter, spring and autumn followed, and the last was summer. Cold and dry evil are the main pathogenic factor.
3. Temperature changes of two groups
64 patients in the observation group had no significant increase in body temperature (accounting for 62.75% of patients in this group), only 27 people's (accounting for 26.47% of patients in this group) temperature above 38℃; In the control group I,34 patients had significantly increase in body temperatures (accounting for 33.33%of patients in this group),45 people's body temperature above 38℃(accounting for 44.12% of patients in this group).
4. Exogenous disease course of two groups
Patients in the observation group with exogenous course of 8-14 days were most (50.98%), followed by 15-30 days (34.31%), and≤7 days (11.76%) and> 30 days (2.94%) were relatively least. Patients in the control group I with≤7天course were most (57.84%), followed by 8-14 days (40.20%),15-30 days at least (1.96%),> 30 days were 0.
5. Changes in renal function between two groups before and after the exogenous disease
After the exogenous disease, renal function in the observation group becomes lower. But in control group I was no significant changes.
6. Changes of symptoms between the two groups before and after the exogenous disease
Before the exogenous disease, symptoms in the observation group patients were varied, these symptoms were further increase among the exogenous disease, after the exogenous disease, symptoms were still exists. In control group I, some symptoms can appear among the exogenous disease, but after the exogenous disease can disappear.
7. Changes in tongue of the two groups
Patients tongue in the observation group are dark-based (including the dark, dark, dim, dark purple), tongue are tired of (including greasy, yellow and greasy) dominated; Patients tongue in control group I were red-based within 72 hours, after external disease was treatment, mainly with pink, white tongue coating are thin, thin yellow-based,
8. Changes in pulse of the two groups
The single pulse in the observation group are heavy, thin, string-based; in the control group I are floating, number and string-based within 72 hours, after external disease was treatment were string, moderate and mainly fine.
9. Stasis in both groups
In addition to the evidence of external diseases, deficiency of yang, deficiency of yin, deficiency of yang and yin, phlegm, blood stasis and stagnation of liver are existence in the observation group; But in the control group I, only the evidence of external diseases can be seen.
PartⅡ:Contrasting between external disease based on internal damage of the Kidney system and external disease without internal damage of the Kidney system by using theory of external diseases based on internal damage.
1. Case Source
In the observation group,39 treatment group cases collected from liang-Duo Jiang Professor's out by treating with traditional Chinese medicine,39 control groupⅡcases were without Liang-duo Jiang Professor treatment, but can 1:1 ratio with treatment group Patients according to gender, age and renal function. Treatment group were all from Liang-duo Jiang Professor Patient, in the control groupⅡ7 patients were from Dongzhimen Hospital Nephrology wards,22 were from other clinics, In each group, there were 13 males and 26 females, male:female=1:2.
2. Treatment
Using study of self-control and compared with oneself before and after. Treatment group treatment by using theory of external diseases based on internal damage, combined with patient's own situation, different decoction was given different patient; control groupⅡwithout a mentor Decoction of patients, their treatment protocols were antibiotics and proprietary therapy.
3. Exogenous disease course of two groups
Exogenous disease course of patients with 8-14 days was maximum (66.67%),≤7 days followed (20.51%),≥15 days was the least (12.82%); control groupⅡexogenous disease course in patients with 8-14 days was maximum of (53.85%),≥15 days followed (38.46%),≤7 days was the least (7.69%).
4. Changes in renal function between two groups before and after the exogenous disease
Renal function had no difference between treatment group and control groupⅡbefore and within 72 hours of external disease, it changed after external disease. And renal function becomes lower in the control groupⅡ.
5. Changes of symptoms between the two groups before and after the exogenous disease
Within 72 hours, two groups of patients with similar symptoms scores, no significant difference; after external disease, patients were more significant differences associated with symptom score. After treatment, the treatment groups of patients with symptoms were alleviated, the control groupⅡpatients with poor symptom improvement.
6. Comparison of two groups of patients with medication
Treatment group are treatment by using theory of external diseases based on internal damage, Chinese herbal formula used by the main agent, according to agent frequency statistics, the top 30 flavor of traditional Chinese medicine are:Bupleurum, Scutellaria root, red peony root, astragalus, Guizhi, raw licorice, Zhimu, CARVACROL, Jiang Ban Xia, wind, Arctium, Codonopsis, paeonol, Atractylodes, Polyporus, Cooked rhubarb, Ligustrum lucidum, forsythia, san qi, Trichosanthes, honeysuckle, mulberry leaves, crane grass, fried almonds, Chrysanthemum, Angelica, mulberry leaf, red sage root, Rehmannia, Fructus real.
Control groupⅡwithout a mentor Decoction of patients, greater use of antibiotics and traditional Chinese medicine, some patients were not taking any medications.
3 Conclusion
1. Pathogenesis of External disease based on internal damage of the Kidney system is complex, deficiency of yang, deficiency of yin, deficiency of yin and yang are the virtual, phlegm, blood stasis, stagnation are also existence.
2. Internal damage of the Kidney system will extend external diseases, disease potential will hard to be cured, external diseases will increase the existing Department of internal injury of renal disease.
3. Sanjiao stagnation is an important pathogenesis in external disease based on internal damage of the Kidney system, treatment should start organs triple burner, Bupleurum are used usually, About internal injury of kidney disease, we should pay attention to benefit qi and make xue live, Li Yang of gas water, spleen and stomach should be taken into account; Against the evil of exogenous drug selection and emphasis should not cold and heat.
4. The theory of external diseases based on internal damage is effective clinical medicine; it comes from clinical practice, not only inherits the essence of the diagnosis and therapy, but also absorbed the new achievements of modern science. It has been proved effectively and can guide Clinical, therefore should be widely applied.
引文
[1]田德禄等.《中医内科学》[M].北京：人民卫生出版社,2002：53-59.
[2]乐鸣.感冒的病因病机及其辨证分型[J].实用中医内科杂志,2002,16(4)：187-188.
[3].刘志强.中医学对感冒的认识与治疗[J].中国医药指南杂志,2008,6(23)：163-164.
[4].张蓉芳.感冒变证辨治[J].中国中医药信息杂志,2007,14(2)：69-70.
[5].姜良铎,秦英,杨君,等.试论“环境毒”[J].中国中医基础医学杂志,1999,5(9)：4-5.
[6].景珊,顾立刚.流行性感冒中医治疗概况[J].中国中医药信息杂志,2008,15(2)：7-8.
1[7].高桂新.东北地区流行性感冒的病因病机辨识[J].中医药学刊,2003,21(1)：2.
[8].任继学.时行感冒[J].中国中医药现代远程教育,2004,2(5)：26-28.
[9].赵兰才.流行性感冒三期论治[J].北京中医杂志,2007,26(11)：719-720.
[10].杨华祥.感冒的中医辨治体会[J].中国社区医师杂志,2008,7(3)：113-114.
[11].王卓颖,张艳文,胡顺利.感冒与脾胃辨证施治[J].中国现代药物应用,2009 3(18)： 151-152
[12].王东,邹平.时行感冒的中医药治疗[J].吉林中医药,2003,6(23)：43.
[13].齐群长.中医药辨证治疗感冒的临床经验[J].中国实用乡村医生杂志,2007,4(14)：34-35.
[14].张秀荣,刘篙平.中医药治疗时行感冒78例[J].河南中医杂志,2002,9(22)：69-70.
[15].张俊庚.时行感冒治疗心得[J].中国中医急症杂志,2002,11(4)：320.
[16].王玉光,周平安.诊治流感经验[J].中国中医药报,2009.6.24
[17].刘均强.感冒的中医辨证治疗[J].社区医学杂志,2008,6(14)：54-55.
[18].范伟赢.体虚感冒的中医辨证论治[J].陕西中医学院学报,2007,30(1)：12-13.
[19].杨华祥.感冒的中医治疗[J].中国社区医师杂志,2008,7(10)：80.
[20].林向东.感冒的中医药治疗[J].吉林中医药,2004,6(25)：41
[21].朱立毅.“羌菊感冒颗粒”治疗急性上呼吸道感染60例[J].江苏中医药,2005,26(11)：52-53.
[22].张朝文.中医对感冒的治疗[J].实用中医药杂志,2008,24(12)：770.
[23].翟华强,向楠.大青龙颗粒治疗感冒风寒表实兼郁热证的临床研究[J].中药新药与临床药理,2005,16(6)：452-453.
[24].毛冰.复方连蒲颗粒治疗感冒(风热证)的随机对照临床试验[J].中国循证医学杂志,2004,4(10)：667-684.
[25].张军瑞.桂枝汤化裁方治疗季节性感冒[J].实用中医药杂志,2009,25(1)：42.
[26].刘兴烈.感冒冲剂治疗风热外感临床研究[J].中国中医急症杂志,2004,13(7)：429-430.
[27].苗德远.藿香正气散加减治疗胃肠型感冒50例[J].实用中医药杂志,2008,24 (4)：224.
[28].王志文.金莲花片治疗感冒风热证或上呼吸道感染多中心、随机、开放阳性药平行对照研究[J].实用医学杂志,2005,21(18)：2085-2086.
[29].罗翌.新香冲剂治疗病毒性上呼吸道感染[J].辽宁中医杂志,2007,34(12)：1726-1728.
[30].闫荣.感冒清热冲剂治疗感冒的临床研究[J].中国实用医学,2004,6(1)：74.
[31].单国君.九味羌活汤加减治疗感冒[J].中医中药杂志,2009,13(1)：79.
[32].黄晓丹.保济浓缩丸治疗胃肠型感冒的临床研究[J].中国民族民间医药,2009,10(4)：44-48.
[33].夏进娥.双黄连超声雾化吸入治疗风热感冒疗效观察[J].实用中医药杂志,2009,25(12)：805.
[34].张安国.疏解汤诒疗感冒139例[J].实用中医药杂志,2009,25(12)：805.
[35].张帆.小柴胡汤加减治疗妊娠感冒68例[J].浙江中医药大学学报,2009,33(1)：80.
[36].顾克辉.培土生金法治疗小儿感冒100例疗效观察[J].国医论坛杂志,2009 24(1)：26-27.
[37].夏以琳.防感散预防小儿感冒的临床和实验研究[J].上海中医药杂志,2007,38(7)：35-37.
[38].曾万玲.感冒康滴鼻液的实验研究[J].中国药物与临床杂志,2003,3(4)：350-351.
[39].张晓慧.感通颗粒抗感冒作用的实验研究[J].中国临床药理学与治疗学,2004,9(10)：1187-1188.
[40].王训乐.银荆感冒颗粒解热作用的实验研究[J].东南大学学报,2008,27(1)：10-12.
[41].李合国.补肾固表方治疗小儿反复呼吸道感染作用机理的实验研究[J].中国中医药信息杂志,2002,9(8)：15-17.
[42].徐晓玉.防感片对小鼠脾细胞分泌IL-2影响的实验研究[J].中国实验方剂学杂志,2002,8(4)：34-36.
[43].林媛.高树彬教授治疗肺系病症经验谈[J].中国中医药杂志,2007,4(31)：78-79.
[44].王惠君.黄文政教授诊治感冒及其变证的经验[J].天津中医杂志,2001,18(4)：1-2.
[45].邵智谦.邵金阶论治感冒的经验[J].湖北中医杂志,2006,28(8)：17-18.
[46].陆汝.吴良德辨证治疗感冒的经验[J].河北中医杂志,2006,28(11)：805-806.
[47].原丹.肖诏玮老中医诊治小儿感冒临证经验初探[J].福建中医药杂志,2008,39(1)： 17-18.
[48].邓沂.于已百教授治疗感冒的经验[J].甘肃中医学院学报,2000,17(4)：1-2.
[49].杨铮.周耀庭教授治疗小儿感冒的临床经验[J].陕西中医药杂志,2008,29(3)：322-323.
[50].李利荣.朱建贵辨治感冒经验浅析[J].北京中医杂志,2007,26(3)：150-151.
[51].胡旭.流行性感冒的中医诊治体会[J].浙江中医药大学学报,2008,32(6)：9-10.
[52].汪玉冠.流行性感冒中医药防治的临床与实验研究进展[J].中国中医药科技杂志,2008,15：(3)：236-237.
[53].王伟.中医药治疗流行性感冒研究进展[J].中国中医药信息杂志,2005,12(8)：102-103.
[54].李文旭.流行性感冒的中医学认识与临床[J].中医研究杂志,1996,9(2)：1.
[55].黎汉光.穿唬宁注射液合三石汤加减治疗夏季重症流感疗效观察[J].中国中医急症杂志,2005,14(6)：543.
[56].张杰,薛玉凤,赵聚宾,等.清毒退热散治疗流行性感冒的临床观察[J].河北中医,2005,4：248.
[57].张晓梅,姜良铎,商学征,等.柴胡桂枝汤加味方汤剂与颗粒剂治疗流行性感冒疗效对比研究[J].中国中医急症.2002,11(3)：174.
[58].曾庆祥,胡德珍.银麻合剂治疗温热流行性感冒的退热效果观察[J].中国中西医结合急救杂志,2004,11(3)：176.
[59].张忠,钟晓玲,熊广,等.病炎清治疗A,B型流感病毒性急性支气管炎116例[J].实用临床中药杂志,2005,9(8)：55.
[60].李德宝.莪术油治疗小儿乙型流感病毒性肺炎疗效观察[J].海南医学杂志,2003,14(11)：46.
[61].王秀东.改良白虎汤治疗流行性感冒91例观察[J].实用中医药杂志,2005,21(8)：465.
[62].陈和.加味麻杏石甘汤治疗流行性感冒195例疗效观察[J].国际医药卫生导报,2006,12(11)：80.
[63].范秀华,刘波.荆防银翘汤治疗冬季流120例[J].实用中医内科杂志,2003,17(3)：191.
[64].胡兆明.柴胡桂枝汤治疗流行性感冒疗效分析[J].时珍国医国药杂志,1998,9(5)：404.
[65].刘俊玲,王晓燕.鱼腥草注射液治疗流感病毒性肺炎80例[J].辽宁中医杂志,2002,29(6)：502.
[66].曲敬来,高雪,周岁锋,等.痰热清注射液治疗流感病毒A型上呼吸道感染临床观察.中国中医急症杂志,2005,14(1)：26.
[67].许健.大青龙汤治疗流感发热临床观察[J].长春中医学院学报,2001,17(2)：29.
[68].奚肇庆,刁人政.银花解毒颗粒治疗流行性感冒风热证临床观察[J].中国中医急症,2003,12(1)：20.
[69].刘盛,陈万生,乔传卓,等.不同种质板蓝根和大青叶的抗甲型流感病毒作用第二军医大学学报,2000,21(3)：204.
[70].刘培民,张鸿彩,包培蓉.升降散抗流感病毒实验研究[J].山东中医药大学学 报,2001,25(1)：43-45.
[71].李际强,张奉学,符林春,等.升降散在体外抗甲型流感病毒的作用与对病毒血凝滴度的影响[J].中医药学刊,2003,21(2)：217-218.
[72].莫日根,韩雪梅,新燕,等.蒿芩清胆汤抗流感病毒的实验研究[J].中医研究,2005,18(5)：16-18.
[73].李丽娅,凌秋,崔洪波,等.黄芪多糖抗流感病毒的实验研究[J].中国中医药科技,2002,9(6)：354.
[74].严银芳,陈晓,杨小清,等.石香藉挥发油抗流感病毒活性成分的初步研究[J].青岛大学医学院学报,2002,38(2)：155-157.
[75].樊宏伟,卢继红,张蓉.苦参碱类生物碱的体外抑茵、抑病毒及诱生干扰素的实验研究[J].中医药信息杂志,2000,(4)：75-76.
[76].赵文明,郑群,刘振龙,等.儿茶提取物抗甲型流感病毒作用的实验研究[J].首都医科大学学报,2005,26(2)：167-170.
[77].卢芳国,田道法,朱应武,等.麻杏甘石汤加味方对A型流感病毒感染小鼠免疫功能的影响[J].中国药学报,2005,33(2)：36.
[78].王成祥,高贵新,魏守超等.益气清瘟解毒合剂对流感病毒FM1感染小鼠肺中IFN-γ TNF-αIL-10及IL-6蛋白动态表达的影响[J].中国中药杂志,2005,30(7)：541.
[79].郝钰,史利卿,段丽颖,等.宣肺透解剂对流感病毒性肺炎小鼠肺部炎症及炎症相关细胞因子的影响[J].中国中西医结合急救杂,2006,13(4)：198.
[80].徐泊文,郝红,吴君,等.加味宣肺透解剂对流感病毒感染小鼠肺组织中炎性细胞因子表达的影响[J].中医药学刊,2006,24(8)：1482.
[81].张炜,李文,毕小利.补肾益肺胶囊预防流感病毒FMl感染小鼠的实验研究[J].中国中医基础医学杂志,2002,8(10)：29.
[82].胡旭,邱全瑛,姜良铎.胚芽滋养胶囊对流感病毒感染小鼠血清IL-2和TNF-α的影响[J].中国中医急症杂志,2004,13(5)：306.
[83].唐光华.姜良铎教授治疗呼吸道病毒感染经验[J].中国中医急症杂志,2004,13(10)：674-675.
[84].杨卓.王长洪教授运用柴胡桂枝汤的经验述要[J].中医药学刊,2005,23(5)：795-796.
[85].徐新毅.陈清维教授治疗流行性感冒经验[J].贵阳中医学院学报,2006,28(3)：20.
[1].姜良铎.论外感病的内伤基础[J].中医杂志,1994,35(4)：201-202.
[2].郭丽华.外感兼有内伤基础病的中医证治探讨[J].四川中医杂志,2008,26(6)：23-24.
[3].王宁群,王东海.和解少阳法治疗内伤基础上外感咳嗽的思路探析[J].中国中医药信息杂志,2005,12(5)：88-89.
[4].张治祥,姜良铎.论祛风解表药在内伤杂症中的运用[J].陕西中医学院学报,2000,23(2)：16-17.
[5].刘承,姜良铎.论脾胃内伤基础上的外感病辨治[J].中国中医急症杂志,2007,16(2)： 177-178.
[6].李东.肃肺降胃法治疗胃内伤基础上外感咳嗽的理论与临床研究[D].北京：北京中医药大学,2002.
[7].毕朔梅.新加坡区域外感咳嗽中医证候特征研究[D].北京：北京中医药大学,2006.
[8].王敏.风药在内伤病证的应用述略[J].中医研究杂志,2005,18(8)：49-50.
[9].刘承,姜良铎.论脾胃内伤基础上的外感病辨治[J].中国中医急症杂志,2007,16(2)：177-178.
[10].王宁群,王东海.和解少阳法治疗内伤基础上外感咳嗽的思路探析[J].中国中医药信息杂志,2005,12(5)：88-89.
[11].贾秀琴.慢性肾炎复发与加重原因及中医药防治对策探析[J].光明中医杂志,2008,23(8)：1065-1066.
[12].王忠武,刘耀坤,陈志雄.祛风法治疗肾小球疾病外感证理论探讨[J].中医药学报,2004,32(2)：1-3.
[13].王岂超,卢树丽.肾炎与上感的联系及中医治疗[J].实用中西医结合杂志，1992,5(9)：548-550.
[14].王力.浅谈慢性肾功能衰竭外感病的辨治特点[J].World Health Digest,2007, 4(5):133.
[15].郭丽华.外感兼有内伤基础病的中医证治探讨[J].四川中医杂志,2008,26(6)：23-24.
[16].叶景华.肾炎外感诊治体会[J].上海中医药杂志,2000,(10)：17-18.
[1].徐勇胜.鼻病毒与气道炎症的研究进展[J].临床儿科杂志,2009,27(5)：491-492.
[2].刘彦明.流感病毒的致病机理研究进展[J].中日友好医院学报,2009,23：(3)：1.
[3].兰喜.冠状病毒的分子生物学研究进展[J].基础医学与临床杂志,2005,25(12)：1095-1096.
[4].Bruzzone MS Fuentes L.Spencer E Specific subgroup B adenovirus diagnosis by PCR of the fibre gene J Infect,2000,40:154-159.
[5].崔玉霞.呼吸道合胞病毒感染及反义基因治疗的研究进展[J].中华儿科杂志,2006,44(8)：629-630.
[6].CDC What to do if you get flu-like symptoms [DB/OL]. (2009-05-02). http:/ /WWW. cdc. gov/hlnlnu/sick htm.
[7].陈新谦,金有豫,汤光.新编药物学[M].16版.北京：人民卫生出版社,2007：166,603.
[8].Jefferson T,Demicheli,V,Deeks,et al.Amantadine,and rimatadine for preventing and treating influenza A in adults[J] Pharmacoeconomics,1999,16 Suppl 1:85-9.
[9].Graeme L,Elspeth G.The origin and control of pandemic influenza[J].Science,2001.29:1776-7
[10].Cheer SM,Wagstaff AJ.Zanamivir:update of its use in influenza[J].Drugs,2002.62(1):71-106.
[11].Monto AS Pichichero ME Blanckeab erg sj,et.al.Zanamivir prophylaxis:an effective strategy for the orevention of influenza types A and B within househdds[J].Infect Dis,2002,186(11):1582-8.
[12].Hirji Z,O'Grady s,Bonham J,et al.Vtility of zanamivir for chemoprophylaxis of concomitaut influeaza A and B in a complex continuing care population[J].infect control Hosp Epidemol,2002,23(10):604-8.
[13].Chand P,Bantia S,Kotian PL,et al.Comparison of the anti-influenza Virus activity of cyclopentance devivatives with oseltamivir and zanamivir in vivo[J].Bioozg Med chem.,2005,13(12):4071-4077.
[14].Alymova Ⅳ,Taylor G,Portner A.Neuraminidase inhibitors as antiviral agents[J].Curr Drug Targets Infect Disord,2005,5(4):401-409.
[15].Li J,zheng M,Tang W et al.Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities[J].Bioozg Med chem. Lett,2006,16(19):5009-5013
[16].Russel RJ,Haire LF,Stevens,DJ,et al.The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design[J].Nature,2006,443(7107):45-19.
[17].申红.利巴韦林不同给药途径治疗婴幼儿上呼吸道感染的临床观察[J].儿科药 学杂志,2006,12(2)：28-29.
[18].张福林.干扰素治疗流行性感冒的临床评价[J].中华今日医学杂志,2004,4(3)：17-18.
[19].刘宏博.盐酸阿比朵尔片治疗流行性感冒的多中心随机双盲平行对照临床研究[J].中国临床药理学杂志,2006,22(6)：403-404.
[20]Jefferson T,Demicheli V,Rivetti D,et al.Antivirals for influenza in healtly adults:systematic review [J].Lancet,2006,367(9507):303-313.
[1].NationalKidneyFoundationKidney.K/DOQIclinicalpracticeguidelinesforchronicki dneydisease:evaluation,classificationandstratificatiori[J].AmJKidneyDis,2002,39(supp ly):1-266.
[2].CollinsAJ,CouserWG,DirksJH,etal.Worldkidneyday:anideawhosetimehascome[J]. AmJKidneyDis,2006,47:375-377.
[3].陈香美,章友康.积极宣传世界肾脏日.唤起全社会对慢性肾脏病的重视[J].中华肾脏病杂志,2006,22：65-66.
[4].National.KidneyFoundation.KEEP2005annualdatareport[J].AmJKidneyDis,2005,4 6(supply):2-4.
[5].张路霞,左力,徐国宾,等.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22：67-71.
[6].郑法雷.迎接挑战,扎实工作,实现慢性肾脏病防治的优化[J].中华肾脏病杂志,2006,22：191-192.
[7].Yue-HamNg,MeyerKB,KusekJW,etal.Hemodialysistiming,survival,andcardiovasc ularoutcomesinthehemodialysis(HEMO)study.AmJKidneyDis,2006,47:614-624.
[2]乐鸣.感冒的病因病机及其辨证分型[J].实用中医内科杂志,2002,16(4)：187-188.
[3].刘志强.中医学对感冒的认识与治疗[J].中国医药指南杂志,2008,6(23)：163-164.
[4].张蓉芳.感冒变证辨治[J].中国中医药信息杂志,2007,14(2)：69-70.
[5].姜良铎,秦英,杨君,等.试论“环境毒”[J].中国中医基础医学杂志,1999,5(9)：4-5.
[6].景珊,顾立刚.流行性感冒中医治疗概况[J].中国中医药信息杂志,2008,15(2)：7-8.
1[7].高桂新.东北地区流行性感冒的病因病机辨识[J].中医药学刊,2003,21(1)：2.
[8].任继学.时行感冒[J].中国中医药现代远程教育,2004,2(5)：26-28.
[9].赵兰才.流行性感冒三期论治[J].北京中医杂志,2007,26(11)：719-720.
[10].杨华祥.感冒的中医辨治体会[J].中国社区医师杂志,2008,7(3)：113-114.
[11].王卓颖,张艳文,胡顺利.感冒与脾胃辨证施治[J].中国现代药物应用,2009 3(18)： 151-152
[12].王东,邹平.时行感冒的中医药治疗[J].吉林中医药,2003,6(23)：43.
[13].齐群长.中医药辨证治疗感冒的临床经验[J].中国实用乡村医生杂志,2007,4(14)：34-35.
[14].张秀荣,刘篙平.中医药治疗时行感冒78例[J].河南中医杂志,2002,9(22)：69-70.
[15].张俊庚.时行感冒治疗心得[J].中国中医急症杂志,2002,11(4)：320.
[16].王玉光,周平安.诊治流感经验[J].中国中医药报,2009.6.24
[17].刘均强.感冒的中医辨证治疗[J].社区医学杂志,2008,6(14)：54-55.
[18].范伟赢.体虚感冒的中医辨证论治[J].陕西中医学院学报,2007,30(1)：12-13.
[19].杨华祥.感冒的中医治疗[J].中国社区医师杂志,2008,7(10)：80.
[20].林向东.感冒的中医药治疗[J].吉林中医药,2004,6(25)：41
[21].朱立毅.“羌菊感冒颗粒”治疗急性上呼吸道感染60例[J].江苏中医药,2005,26(11)：52-53.
[22].张朝文.中医对感冒的治疗[J].实用中医药杂志,2008,24(12)：770.
[23].翟华强,向楠.大青龙颗粒治疗感冒风寒表实兼郁热证的临床研究[J].中药新药与临床药理,2005,16(6)：452-453.
[24].毛冰.复方连蒲颗粒治疗感冒(风热证)的随机对照临床试验[J].中国循证医学杂志,2004,4(10)：667-684.
[25].张军瑞.桂枝汤化裁方治疗季节性感冒[J].实用中医药杂志,2009,25(1)：42.
[26].刘兴烈.感冒冲剂治疗风热外感临床研究[J].中国中医急症杂志,2004,13(7)：429-430.
[27].苗德远.藿香正气散加减治疗胃肠型感冒50例[J].实用中医药杂志,2008,24 (4)：224.
[28].王志文.金莲花片治疗感冒风热证或上呼吸道感染多中心、随机、开放阳性药平行对照研究[J].实用医学杂志,2005,21(18)：2085-2086.
[29].罗翌.新香冲剂治疗病毒性上呼吸道感染[J].辽宁中医杂志,2007,34(12)：1726-1728.
[30].闫荣.感冒清热冲剂治疗感冒的临床研究[J].中国实用医学,2004,6(1)：74.
[31].单国君.九味羌活汤加减治疗感冒[J].中医中药杂志,2009,13(1)：79.
[32].黄晓丹.保济浓缩丸治疗胃肠型感冒的临床研究[J].中国民族民间医药,2009,10(4)：44-48.
[33].夏进娥.双黄连超声雾化吸入治疗风热感冒疗效观察[J].实用中医药杂志,2009,25(12)：805.
[34].张安国.疏解汤诒疗感冒139例[J].实用中医药杂志,2009,25(12)：805.
[35].张帆.小柴胡汤加减治疗妊娠感冒68例[J].浙江中医药大学学报,2009,33(1)：80.
[36].顾克辉.培土生金法治疗小儿感冒100例疗效观察[J].国医论坛杂志,2009 24(1)：26-27.
[37].夏以琳.防感散预防小儿感冒的临床和实验研究[J].上海中医药杂志,2007,38(7)：35-37.
[38].曾万玲.感冒康滴鼻液的实验研究[J].中国药物与临床杂志,2003,3(4)：350-351.
[39].张晓慧.感通颗粒抗感冒作用的实验研究[J].中国临床药理学与治疗学,2004,9(10)：1187-1188.
[40].王训乐.银荆感冒颗粒解热作用的实验研究[J].东南大学学报,2008,27(1)：10-12.
[41].李合国.补肾固表方治疗小儿反复呼吸道感染作用机理的实验研究[J].中国中医药信息杂志,2002,9(8)：15-17.
[42].徐晓玉.防感片对小鼠脾细胞分泌IL-2影响的实验研究[J].中国实验方剂学杂志,2002,8(4)：34-36.
[43].林媛.高树彬教授治疗肺系病症经验谈[J].中国中医药杂志,2007,4(31)：78-79.
[44].王惠君.黄文政教授诊治感冒及其变证的经验[J].天津中医杂志,2001,18(4)：1-2.
[45].邵智谦.邵金阶论治感冒的经验[J].湖北中医杂志,2006,28(8)：17-18.
[46].陆汝.吴良德辨证治疗感冒的经验[J].河北中医杂志,2006,28(11)：805-806.
[47].原丹.肖诏玮老中医诊治小儿感冒临证经验初探[J].福建中医药杂志,2008,39(1)： 17-18.
[48].邓沂.于已百教授治疗感冒的经验[J].甘肃中医学院学报,2000,17(4)：1-2.
[49].杨铮.周耀庭教授治疗小儿感冒的临床经验[J].陕西中医药杂志,2008,29(3)：322-323.
[50].李利荣.朱建贵辨治感冒经验浅析[J].北京中医杂志,2007,26(3)：150-151.
[51].胡旭.流行性感冒的中医诊治体会[J].浙江中医药大学学报,2008,32(6)：9-10.
[52].汪玉冠.流行性感冒中医药防治的临床与实验研究进展[J].中国中医药科技杂志,2008,15：(3)：236-237.
[53].王伟.中医药治疗流行性感冒研究进展[J].中国中医药信息杂志,2005,12(8)：102-103.
[54].李文旭.流行性感冒的中医学认识与临床[J].中医研究杂志,1996,9(2)：1.
[55].黎汉光.穿唬宁注射液合三石汤加减治疗夏季重症流感疗效观察[J].中国中医急症杂志,2005,14(6)：543.
[56].张杰,薛玉凤,赵聚宾,等.清毒退热散治疗流行性感冒的临床观察[J].河北中医,2005,4：248.
[57].张晓梅,姜良铎,商学征,等.柴胡桂枝汤加味方汤剂与颗粒剂治疗流行性感冒疗效对比研究[J].中国中医急症.2002,11(3)：174.
[58].曾庆祥,胡德珍.银麻合剂治疗温热流行性感冒的退热效果观察[J].中国中西医结合急救杂志,2004,11(3)：176.
[59].张忠,钟晓玲,熊广,等.病炎清治疗A,B型流感病毒性急性支气管炎116例[J].实用临床中药杂志,2005,9(8)：55.
[60].李德宝.莪术油治疗小儿乙型流感病毒性肺炎疗效观察[J].海南医学杂志,2003,14(11)：46.
[61].王秀东.改良白虎汤治疗流行性感冒91例观察[J].实用中医药杂志,2005,21(8)：465.
[62].陈和.加味麻杏石甘汤治疗流行性感冒195例疗效观察[J].国际医药卫生导报,2006,12(11)：80.
[63].范秀华,刘波.荆防银翘汤治疗冬季流120例[J].实用中医内科杂志,2003,17(3)：191.
[64].胡兆明.柴胡桂枝汤治疗流行性感冒疗效分析[J].时珍国医国药杂志,1998,9(5)：404.
[65].刘俊玲,王晓燕.鱼腥草注射液治疗流感病毒性肺炎80例[J].辽宁中医杂志,2002,29(6)：502.
[66].曲敬来,高雪,周岁锋,等.痰热清注射液治疗流感病毒A型上呼吸道感染临床观察.中国中医急症杂志,2005,14(1)：26.
[67].许健.大青龙汤治疗流感发热临床观察[J].长春中医学院学报,2001,17(2)：29.
[68].奚肇庆,刁人政.银花解毒颗粒治疗流行性感冒风热证临床观察[J].中国中医急症,2003,12(1)：20.
[69].刘盛,陈万生,乔传卓,等.不同种质板蓝根和大青叶的抗甲型流感病毒作用第二军医大学学报,2000,21(3)：204.
[70].刘培民,张鸿彩,包培蓉.升降散抗流感病毒实验研究[J].山东中医药大学学 报,2001,25(1)：43-45.
[71].李际强,张奉学,符林春,等.升降散在体外抗甲型流感病毒的作用与对病毒血凝滴度的影响[J].中医药学刊,2003,21(2)：217-218.
[72].莫日根,韩雪梅,新燕,等.蒿芩清胆汤抗流感病毒的实验研究[J].中医研究,2005,18(5)：16-18.
[73].李丽娅,凌秋,崔洪波,等.黄芪多糖抗流感病毒的实验研究[J].中国中医药科技,2002,9(6)：354.
[74].严银芳,陈晓,杨小清,等.石香藉挥发油抗流感病毒活性成分的初步研究[J].青岛大学医学院学报,2002,38(2)：155-157.
[75].樊宏伟,卢继红,张蓉.苦参碱类生物碱的体外抑茵、抑病毒及诱生干扰素的实验研究[J].中医药信息杂志,2000,(4)：75-76.
[76].赵文明,郑群,刘振龙,等.儿茶提取物抗甲型流感病毒作用的实验研究[J].首都医科大学学报,2005,26(2)：167-170.
[77].卢芳国,田道法,朱应武,等.麻杏甘石汤加味方对A型流感病毒感染小鼠免疫功能的影响[J].中国药学报,2005,33(2)：36.
[78].王成祥,高贵新,魏守超等.益气清瘟解毒合剂对流感病毒FM1感染小鼠肺中IFN-γ TNF-αIL-10及IL-6蛋白动态表达的影响[J].中国中药杂志,2005,30(7)：541.
[79].郝钰,史利卿,段丽颖,等.宣肺透解剂对流感病毒性肺炎小鼠肺部炎症及炎症相关细胞因子的影响[J].中国中西医结合急救杂,2006,13(4)：198.
[80].徐泊文,郝红,吴君,等.加味宣肺透解剂对流感病毒感染小鼠肺组织中炎性细胞因子表达的影响[J].中医药学刊,2006,24(8)：1482.
[81].张炜,李文,毕小利.补肾益肺胶囊预防流感病毒FMl感染小鼠的实验研究[J].中国中医基础医学杂志,2002,8(10)：29.
[82].胡旭,邱全瑛,姜良铎.胚芽滋养胶囊对流感病毒感染小鼠血清IL-2和TNF-α的影响[J].中国中医急症杂志,2004,13(5)：306.
[83].唐光华.姜良铎教授治疗呼吸道病毒感染经验[J].中国中医急症杂志,2004,13(10)：674-675.
[84].杨卓.王长洪教授运用柴胡桂枝汤的经验述要[J].中医药学刊,2005,23(5)：795-796.
[85].徐新毅.陈清维教授治疗流行性感冒经验[J].贵阳中医学院学报,2006,28(3)：20.
[1].姜良铎.论外感病的内伤基础[J].中医杂志,1994,35(4)：201-202.
[2].郭丽华.外感兼有内伤基础病的中医证治探讨[J].四川中医杂志,2008,26(6)：23-24.
[3].王宁群,王东海.和解少阳法治疗内伤基础上外感咳嗽的思路探析[J].中国中医药信息杂志,2005,12(5)：88-89.
[4].张治祥,姜良铎.论祛风解表药在内伤杂症中的运用[J].陕西中医学院学报,2000,23(2)：16-17.
[5].刘承,姜良铎.论脾胃内伤基础上的外感病辨治[J].中国中医急症杂志,2007,16(2)： 177-178.
[6].李东.肃肺降胃法治疗胃内伤基础上外感咳嗽的理论与临床研究[D].北京：北京中医药大学,2002.
[7].毕朔梅.新加坡区域外感咳嗽中医证候特征研究[D].北京：北京中医药大学,2006.
[8].王敏.风药在内伤病证的应用述略[J].中医研究杂志,2005,18(8)：49-50.
[9].刘承,姜良铎.论脾胃内伤基础上的外感病辨治[J].中国中医急症杂志,2007,16(2)：177-178.
[10].王宁群,王东海.和解少阳法治疗内伤基础上外感咳嗽的思路探析[J].中国中医药信息杂志,2005,12(5)：88-89.
[11].贾秀琴.慢性肾炎复发与加重原因及中医药防治对策探析[J].光明中医杂志,2008,23(8)：1065-1066.
[12].王忠武,刘耀坤,陈志雄.祛风法治疗肾小球疾病外感证理论探讨[J].中医药学报,2004,32(2)：1-3.
[13].王岂超,卢树丽.肾炎与上感的联系及中医治疗[J].实用中西医结合杂志，1992,5(9)：548-550.
[14].王力.浅谈慢性肾功能衰竭外感病的辨治特点[J].World Health Digest,2007, 4(5):133.
[15].郭丽华.外感兼有内伤基础病的中医证治探讨[J].四川中医杂志,2008,26(6)：23-24.
[16].叶景华.肾炎外感诊治体会[J].上海中医药杂志,2000,(10)：17-18.
[1].徐勇胜.鼻病毒与气道炎症的研究进展[J].临床儿科杂志,2009,27(5)：491-492.
[2].刘彦明.流感病毒的致病机理研究进展[J].中日友好医院学报,2009,23：(3)：1.
[3].兰喜.冠状病毒的分子生物学研究进展[J].基础医学与临床杂志,2005,25(12)：1095-1096.
[4].Bruzzone MS Fuentes L.Spencer E Specific subgroup B adenovirus diagnosis by PCR of the fibre gene J Infect,2000,40:154-159.
[5].崔玉霞.呼吸道合胞病毒感染及反义基因治疗的研究进展[J].中华儿科杂志,2006,44(8)：629-630.
[6].CDC What to do if you get flu-like symptoms [DB/OL]. (2009-05-02). http:/ /WWW. cdc. gov/hlnlnu/sick htm.
[7].陈新谦,金有豫,汤光.新编药物学[M].16版.北京：人民卫生出版社,2007：166,603.
[8].Jefferson T,Demicheli,V,Deeks,et al.Amantadine,and rimatadine for preventing and treating influenza A in adults[J] Pharmacoeconomics,1999,16 Suppl 1:85-9.
[9].Graeme L,Elspeth G.The origin and control of pandemic influenza[J].Science,2001.29:1776-7
[10].Cheer SM,Wagstaff AJ.Zanamivir:update of its use in influenza[J].Drugs,2002.62(1):71-106.
[11].Monto AS Pichichero ME Blanckeab erg sj,et.al.Zanamivir prophylaxis:an effective strategy for the orevention of influenza types A and B within househdds[J].Infect Dis,2002,186(11):1582-8.
[12].Hirji Z,O'Grady s,Bonham J,et al.Vtility of zanamivir for chemoprophylaxis of concomitaut influeaza A and B in a complex continuing care population[J].infect control Hosp Epidemol,2002,23(10):604-8.
[13].Chand P,Bantia S,Kotian PL,et al.Comparison of the anti-influenza Virus activity of cyclopentance devivatives with oseltamivir and zanamivir in vivo[J].Bioozg Med chem.,2005,13(12):4071-4077.
[14].Alymova Ⅳ,Taylor G,Portner A.Neuraminidase inhibitors as antiviral agents[J].Curr Drug Targets Infect Disord,2005,5(4):401-409.
[15].Li J,zheng M,Tang W et al.Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities[J].Bioozg Med chem. Lett,2006,16(19):5009-5013
[16].Russel RJ,Haire LF,Stevens,DJ,et al.The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design[J].Nature,2006,443(7107):45-19.
[17].申红.利巴韦林不同给药途径治疗婴幼儿上呼吸道感染的临床观察[J].儿科药 学杂志,2006,12(2)：28-29.
[18].张福林.干扰素治疗流行性感冒的临床评价[J].中华今日医学杂志,2004,4(3)：17-18.
[19].刘宏博.盐酸阿比朵尔片治疗流行性感冒的多中心随机双盲平行对照临床研究[J].中国临床药理学杂志,2006,22(6)：403-404.
[20]Jefferson T,Demicheli V,Rivetti D,et al.Antivirals for influenza in healtly adults:systematic review [J].Lancet,2006,367(9507):303-313.
[1].NationalKidneyFoundationKidney.K/DOQIclinicalpracticeguidelinesforchronicki dneydisease:evaluation,classificationandstratificatiori[J].AmJKidneyDis,2002,39(supp ly):1-266.
[2].CollinsAJ,CouserWG,DirksJH,etal.Worldkidneyday:anideawhosetimehascome[J]. AmJKidneyDis,2006,47:375-377.
[3].陈香美,章友康.积极宣传世界肾脏日.唤起全社会对慢性肾脏病的重视[J].中华肾脏病杂志,2006,22：65-66.
[4].National.KidneyFoundation.KEEP2005annualdatareport[J].AmJKidneyDis,2005,4 6(supply):2-4.
[5].张路霞,左力,徐国宾,等.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22：67-71.
[6].郑法雷.迎接挑战,扎实工作,实现慢性肾脏病防治的优化[J].中华肾脏病杂志,2006,22：191-192.
[7].Yue-HamNg,MeyerKB,KusekJW,etal.Hemodialysistiming,survival,andcardiovasc ularoutcomesinthehemodialysis(HEMO)study.AmJKidneyDis,2006,47:614-624.